Shionogi Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Shionogi Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3435
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shionogi Inc (Shionogi), a subsidiary of Shionogi & Co., Ltd, is a pharmaceutical company that develops and commercializes pharmaceutical products to address the unmet medical needs. The company offers a wide range of branded prescription products to treat chronic diseases. It markets products for various therapeutic areas such as pain, anti-infectives, women’s health, pediatrics, cardiovascular and others. Shionogi offers its products in various formulations such as tablets, oral suspensions (solutions), lotions, capsules, chewable tablets and injections. Some of the company’s key branded products include Doribax, Fortamet, Methylin, Ponstel and Xodol, among others. Shionogi is headquartered in Florham Park, New Jersey, the US.

Shionogi Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shionogi Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shionogi Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Shionogi Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Noven Pharma Enters Into Co-Promotion Agreement With Shionogi For Brisdelle Capsules 10
Licensing Agreements 11
Pharmbio Korea Enters into Licensing Agreement with Shionogi 11
Duchesnay Receives Rights for Osphena from Shionogi 12
Plethora Solutions Enters Into Commercialization Agreement With Shionogi For PSD502 13
Concordia Pharma And Shionogi Enter Into Licensing Agreement For Ulesfia 14
Equity Offering 15
PharmaIN to Raise USD17 Million in Private Placement of Shares 15
Asset Transactions 16
Pragma Pharma Acquires Keflex from Shionogi 16
Alvogen Acquires Rights Of Naprelan Tablets From Shionogi 17
Concordia Pharma Acquires Rights To Three US Pediatrics From Shionogi 18
Merz Pharma Acquires Cuvposa from Shionogi 19
Shionogi Inc – Key Competitors 20
Shionogi Inc – Key Employees 21
Shionogi Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Corporate Communications 23
May 09, 2018: Shionogi to Announce Executive Appointment 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Shionogi Inc, Pharmaceuticals & Healthcare, Key Facts 2
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shionogi Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shionogi Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Shionogi Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Noven Pharma Enters Into Co-Promotion Agreement With Shionogi For Brisdelle Capsules 10
Pharmbio Korea Enters into Licensing Agreement with Shionogi 11
Duchesnay Receives Rights for Osphena from Shionogi 12
Plethora Solutions Enters Into Commercialization Agreement With Shionogi For PSD502 13
Concordia Pharma And Shionogi Enter Into Licensing Agreement For Ulesfia 14
PharmaIN to Raise USD17 Million in Private Placement of Shares 15
Pragma Pharma Acquires Keflex from Shionogi 16
Alvogen Acquires Rights Of Naprelan Tablets From Shionogi 17
Concordia Pharma Acquires Rights To Three US Pediatrics From Shionogi 18
Merz Pharma Acquires Cuvposa from Shionogi 19
Shionogi Inc, Key Competitors 20
Shionogi Inc, Key Employees 21

List of Figures
Shionogi Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shionogi Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shionogi Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Shionogi Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DPT Laboratories Ltd:企業の戦略的SWOT分析
    DPT Laboratories Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Hindustan Petroleum Corp Ltd (HINDPETRO):企業の財務・戦略的SWOT分析
    Hindustan Petroleum Corp Ltd (HINDPETRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • maxingvest ag:企業の戦略・SWOT・財務情報
    maxingvest ag - Strategy, SWOT and Corporate Finance Report Summary maxingvest ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Gold Fields Limited:企業のM&A・事業提携・投資動向
    Gold Fields Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Gold Fields Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Eng Kah Corporation Berhad:戦略・SWOT・企業財務分析
    Eng Kah Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Eng Kah Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Caprion Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Caprion Biosciences Inc (Caprion) is a provider of proteomics and immune monitoring services. The company’s proteomic based services include neo-epitope discovery and characterization, biomarker discovery, fit-for-purpose assays, host cell protein detection and PK assays, among others. It of …
  • Pedevco Corp (PED):石油・ガス:M&Aディール及び事業提携情報
    Summary Pedevco Corp (Pedevco), formerly Pacific Energy Development Corp is an oil and gas exploration and development company. The company operates in the acquisition and development of energy projects such as shale oil and gas assets. Its oil and gas asset is located in the D-J Basin in Weld and M …
  • Basic Energy Services Inc (BAS):石油・ガス:M&Aディール及び事業提携情報
    Summary Basic Energy Services Inc (Basic Energy) is an oil and gas company that offers well site services. The company’s services including well servicing, snubbing, water logistics, saltwater disposal, pumping services, coil tubing, water solutions, wireline, contract drilling, coil tubing and tubu …
  • Prakash Constrowell Limited
    Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report Summary Prakash Constrowell Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • GENTEX Corp:企業の戦略的SWOT分析
    GENTEX Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Fortress Investment Group LLC:企業のM&A・事業提携・投資動向
    Fortress Investment Group LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fortress Investment Group LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Hypera SA:企業の戦略・SWOT・財務情報
    Hypera SA - Strategy, SWOT and Corporate Finance Report Summary Hypera SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Fujirebio Europe NV:企業の戦略的SWOT分析
    Fujirebio Europe NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • PTC India Limited (PTC)-エネルギー分野:企業M&A・提携分析
    Summary PTC India Limited (PTC) formerly Power Trading Corporation of India Limited, is a provider of power trading solutions. The company is a public-private partnership entity initiated by the government of India. It carries out trading activities which include, long term trading of power generate …
  • Quantum Utility Generation LLC:電力:M&Aディール及び事業提携情報
    Summary Quantum Utility Generation LLC (QUG) is an electric utility that acquires, develops, operates and optimizes power generation assets in the Americas. The utility generates electricity from various sources such as wind, coal and natural gas-based power generation plants. It also produces elect …
  • Gymboree Group, Inc.:企業の戦略的SWOT分析
    Gymboree Group, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Legg Mason, Inc.:戦略・SWOT・企業財務分析
    Legg Mason, Inc. - Strategy, SWOT and Corporate Finance Report Summary Legg Mason, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • TFS Financial Corp:企業の戦略・SWOT・財務分析
    TFS Financial Corp - Strategy, SWOT and Corporate Finance Report Summary TFS Financial Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • ASUSTeK Computer Inc.:企業の戦略・SWOT・財務情報
    ASUSTeK Computer Inc. - Strategy, SWOT and Corporate Finance Report Summary ASUSTeK Computer Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • VisionCare Inc-医療機器分野:企業M&A・提携分析
    Summary VisionCare Inc (VisionCare) is a medical device company that researches, develops, manufactures, and markets proprietary implantable ophthalmic devices and technologies for the treatment of retinal disorders. The company offers implantable miniature telescope, an implantable medical device t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆